Filter By Category
Archives
BULEVIRTIDE
Generic Name: BULEVIRTIDE
ABSTRACT -
Bulevirtide is a synthetic myristoylated lipopeptide that blocks viral entry by binding NTCP on hepatocytes. It is used for chronic hepatitis delta infection in eligible adult patients with compensated liver disease where approved.
DOSAGE -
Bulevirtide is administered by subcutaneous injection where it is approved for chronic hepatitis delta infection.
- Use only in eligible patients under specialist supervision and according to the current product information.
- Monitoring generally includes liver status, virologic response, tolerability, and bile-salt related laboratory changes.
SIDE EFFECTS-
Common or possible side effects may include:
- Injection-site reaction
- Headache
- Fatigue
- Nausea
- Dizziness
- Raised bile salts
- Liver laboratory changes
- Hypersensitivity reactions
Serious adverse effects depend on dose, route, indication, comorbidities, and concomitant medicines.
ALLERGIC REACTIONS -
Bulevirtide may cause allergic or hypersensitivity reactions. Risk may be higher in patients with previous reactions to related products or excipients.
Symptoms may include:
- Fever
- Skin rash
- Itching
- Hives
- Swelling of face, lips, tongue, or throat
- Wheezing or shortness of breath
- Severe dizziness
- Low blood pressure
- Anaphylaxis in severe cases
Important: Stop treatment and seek urgent medical help if a serious allergic reaction is suspected.
DRUG INTERACTIONS-
Bulevirtide may interact with certain medicines or substances. Caution is needed with:
- Medicines transported by or affecting hepatic bile-acid transport pathways
- Other hepatitis therapies
- Hepatotoxic medicines
- Immunosuppressive medicines when clinically relevant
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, and supplements they are using.
PREAUTONS–
- Use only under medical supervision.
- Review allergy history before use.
- Inform healthcare providers about all medicines and supplements.
- Use caution in pregnancy, breastfeeding, pediatric, geriatric, renal, or hepatic impairment unless specifically evaluated.
- Monitor for infusion or injection reactions.
- Biologic products may require cold-chain handling and trained administration.
WARNINGS –
- Serious hypersensitivity or anaphylaxis may occur.
- Infections or immune-mediated adverse reactions may occur depending on mechanism.
- Use only where monitoring and emergency support are available.
- Keep out of reach of children.



. Developed by